Infosys completes acquisition of BASE life science

02 Sep 2022 Evaluate

Infosys has completed the acquisition of BASE life science, a leading technology and consulting firm in the life sciences industry, in Europe. The acquisition reaffirms Infosys’ commitment to help global life sciences companies realize business value from cloud-first digital platforms and data, to speed-up clinical trials and scale drug development, positively impacting lives and achieving better health outcomes.

BASE further expands Infosys’ footprint in the Nordics region and will bring domain experts with commercial, medical, digital marketing, clinical, regulatory, and quality knowhow. Backed by a team of data science specialists, BASE is at the frontier of the latest technological developments and trends. It has a strong focus on Data & AI, and the ability to bridge and integrate business logic and technology, driving insights for better health outcomes. Together with Infosys, BASE will further expand its portfolio of expertise into Consumer Health, Animal Health, MedTech and Genomics segments. BASE collaborates with leading software technology providers in the life sciences industry such as Veeva, IQVIA and Salesforce.

Infosys is a global leader in next-generation digital services and consulting. 

Infosys Share Price

1689.40 90.35 (5.65%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 3206.70
Infosys 1689.40
HCL Tech. 1698.90
Wipro 267.25
Tech Mahindra 1670.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×